Pub. Date : 2013 Jun
PMID : 23730417
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer. | Oxaliplatin | KRAS proto-oncogene, GTPase | Homo sapiens |
| 2 | In patients who received first-line oxaliplatin-based regimens, the PFS was significantly longer in KRAS mutant patients (N = 32) than that in KRAS wild-type patients (N = 51). | Oxaliplatin | KRAS proto-oncogene, GTPase | Homo sapiens |
| 3 | In patients who received first-line oxaliplatin-based regimens, the PFS was significantly longer in KRAS mutant patients (N = 32) than that in KRAS wild-type patients (N = 51). | Oxaliplatin | KRAS proto-oncogene, GTPase | Homo sapiens |
| 4 | In multivariate analyses, KRAS mutation remains an independent predictive factor for longer PFS in first-line oxaliplatin-based regimens. | Oxaliplatin | KRAS proto-oncogene, GTPase | Homo sapiens |
| 5 | In conclusion, oxaliplatin-based chemotherapy in KRAS mutant mCRC might result in longer PFS than in KRAS wild-type mCRC. | Oxaliplatin | KRAS proto-oncogene, GTPase | Homo sapiens |
| 6 | In conclusion, oxaliplatin-based chemotherapy in KRAS mutant mCRC might result in longer PFS than in KRAS wild-type mCRC. | Oxaliplatin | KRAS proto-oncogene, GTPase | Homo sapiens |